Fig. 5
From: UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
Suppression of UBQLN4 inhibits tumor formation ability of HCC cells in vivo. a–c The in vivo effect of UBQLN4 was evaluated in xenograft mouse models bearing tumors originating from SMMC-7721 cells via tumor volume and photon flux; n = 6 per group. d–f Expression of UBQLN4 and Ki67 were detected between UBQLN4 shRNA and negative control groups in node mouse tumor tissues. *p < 0.05, **p < 0.01